Clinical Trial Update: Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bortezomib-based consolidation in multiple myeloma patients after stem cell transplantation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Mayo Clinic | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2016-06-03